- Home
- TECH vs DLB Comparison
TECH vs DLB Comparison
Compare TECH & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- DLB
- Stock Information
- Founded
- TECH 1976
- DLB 1965
- Country
- TECH United States
- DLB United States
- Employees
- TECH N/A
- DLB N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- DLB Multi-Sector Companies
- Sector
- TECH Health Care
- DLB Miscellaneous
- Exchange
- TECH Nasdaq
- DLB Nasdaq
- Market Cap
- TECH 7.8B
- DLB 7.9B
- IPO Year
- TECH 1989
- DLB 2005
- Fundamental
- Price
- TECH $49.15
- DLB $77.57
- Analyst Decision
- TECH Buy
- DLB Strong Buy
- Analyst Count
- TECH 10
- DLB 4
- Target Price
- TECH $73.44
- DLB $101.75
- AVG Volume (30 Days)
- TECH 2.3M
- DLB 400.0K
- Earning Date
- TECH 05-07-2025
- DLB 05-01-2025
- Dividend Yield
- TECH 0.65%
- DLB 1.71%
- EPS Growth
- TECH N/A
- DLB 36.08
- EPS
- TECH 0.83
- DLB 2.64
- Revenue
- TECH $1,208,770,000.00
- DLB $1,320,184,000.00
- Revenue This Year
- TECH $8.19
- DLB $6.38
- Revenue Next Year
- TECH $8.61
- DLB $4.65
- P/E Ratio
- TECH $59.07
- DLB $29.29
- Revenue Growth
- TECH 4.72
- DLB 4.03
- 52 Week Low
- TECH $46.44
- DLB $66.35
- 52 Week High
- TECH $85.57
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- TECH 44.74
- DLB 56.62
- Support Level
- TECH $46.35
- DLB $76.69
- Resistance Level
- TECH $54.40
- DLB $78.28
- Average True Range (ATR)
- TECH 2.17
- DLB 1.39
- MACD
- TECH 0.27
- DLB 0.47
- Stochastic Oscillator
- TECH 34.78
- DLB 88.03
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.